Insulin therapy in type 2 diabetes – Related resources
05.09.2012 • Sonuncu dəyişiklik 08.03.2007
This article is created and updated by the EBMG Editorial Team
Cochrane reviews
There may be no clinically relevant difference in the efficacy or safety between insulin detemir and insulin glargine for targeting hyperglycaemia in patients with type 2 diabetes. Insulin detemir appears to be associated with a higher daily dose and less weight gain, and insulin glargine with once-daily dosing and fewer injection site reactions.
Literature
- MacMahon GT, Arky RA. Inhaled insulin for diabetes mellitus. N Engl J Med 2007;356:497-502